379 related articles for article (PubMed ID: 15388421)
1. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.
Xiao L; Madison V; Chau AS; Loebenberg D; Palermo RE; McNicholas PM
Antimicrob Agents Chemother; 2004 Feb; 48(2):568-74. PubMed ID: 14742211
[TBL] [Abstract][Full Text] [Related]
3. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Hull CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4223-32. PubMed ID: 22615281
[TBL] [Abstract][Full Text] [Related]
4. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Sanati H; Belanger P; Fratti R; Ghannoum M
Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
[TBL] [Abstract][Full Text] [Related]
5. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Keniya MV; Ruma YN; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
[TBL] [Abstract][Full Text] [Related]
6.
Colley T; Sehra G; Chowdhary A; Alanio A; Kelly SL; Kizawa Y; Armstrong-James D; Fisher MC; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Nishimoto Y; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; McConville M; King-Underwood J; Naylor A; Bretagne S; Murray J; Ito K; Strong P; Rapeport G
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439966
[TBL] [Abstract][Full Text] [Related]
7. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.
Mellado E; Garcia-Effron G; Buitrago MJ; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Jun; 49(6):2536-8. PubMed ID: 15917566
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis.
Heimark L; Shipkova P; Greene J; Munayyer H; Yarosh-Tomaine T; DiDomenico B; Hare R; Pramanik BN
J Mass Spectrom; 2002 Mar; 37(3):265-9. PubMed ID: 11921367
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective interaction of SCH 39304, a triazole, with sterol 14alpha-demethylase of Aspergillus fumigatus.
Venkateswarlu K; Kelly SL
J Antimicrob Chemother; 1997 May; 39(5):597-601. PubMed ID: 9184358
[TBL] [Abstract][Full Text] [Related]
10. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.
Mann PA; Parmegiani RM; Wei SQ; Mendrick CA; Li X; Loebenberg D; DiDomenico B; Hare RS; Walker SS; McNicholas PM
Antimicrob Agents Chemother; 2003 Feb; 47(2):577-81. PubMed ID: 12543662
[TBL] [Abstract][Full Text] [Related]
11.
Colley T; Alanio A; Kelly SL; Sehra G; Kizawa Y; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Anderson-Dring L; Nakaoki T; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; Cooke M; Bretagne S; King-Underwood J; Murray J; Ito K; Strong P; Rapeport G
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223388
[TBL] [Abstract][Full Text] [Related]
12. A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
Ballard SA; Ellis SW; Kelly SL; Troke PF
J Med Vet Mycol; 1990; 28(4):335-44. PubMed ID: 2176688
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
Krishnan-Natesan S; Chandrasekar PH; Alangaden GJ; Manavathu EK
Int J Antimicrob Agents; 2008 Dec; 32(6):519-24. PubMed ID: 18775650
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
15. Estimation of minimum sterol 14alpha-demethylation-inhibitory concentration of azoles in Candida yeasts using acetate-mediated growth inhibition: potential utility in susceptibility testing.
Shimokawa O; Nakayama H
J Clin Microbiol; 2000 Aug; 38(8):2893-6. PubMed ID: 10921946
[TBL] [Abstract][Full Text] [Related]
16. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
[TBL] [Abstract][Full Text] [Related]
17. Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Sagatova AA; Keniya MV; Wilson RK; Monk BC; Tyndall JD
Antimicrob Agents Chemother; 2015 Aug; 59(8):4982-9. PubMed ID: 26055382
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
19. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
20. Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
Keniya MV; Sabherwal M; Wilson RK; Woods MA; Sagatova AA; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
